The aim of current Case-Control study is to evaluate maternal and fetal outcomes among women with morbidly adherent placenta (MAP) in Beni-Suef university hospital and to quantify the predisposing risk factors. The study was conducted from January 2020 to December 2020 in the out-patient and emergency Gynecology and Obstetrics department at Beni-Suef University Hospital. This study included a total of (30) MAP patients and an equal number (30) of matched pregnant females without MAP as a control group. At study inclusion, baseline demographic, past obstetric and medical history were collected first from all participants included in the study, then obstetric ultrasonography (USG) was done to determine position of placenta and type of placenta previa. Parity was significantly higher among women with MAP as compared with women with normal placenta. Number of previous CS was significantly higher among women with MAP. Incidence of antepartum hemorrhage was significantly higher among studied cases with MAP as compared with women with normal placenta with a statistically significant difference. Estimated blood loss (L), incidence of blood transfusion, number of transfused units, and fresh frozen plasma (FFP) transfusion were significantly higher among MAP group. Neonatal weight was significantly lower in MAP women, no statistically significant differences in Apgar score at 1st minute and after 5 minutes in both groups. NICU admission was significantly higher among MAP neonates. In conclusion, Morbidly adherent placenta is associated with several adverse maternal and fetal outcomes. It is a life-threatening hemorrhagic condition associated with high fetal and maternal morbidities and mortalities.